The effect of pharmacological dosages of glucocorticoids on free living total energy expenditure in man
- 1 May 1994
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 40 (5) , 577-581
- https://doi.org/10.1111/j.1365-2265.1994.tb03007.x
Abstract
Weight gain had previously been thought to be due to increased calorie intake alone though no information on its effect on total energy expenditure is available in humans. We therefore assessed whether weight gain associated with glucocorticoids is due to a reduction in energy expenditure. We performed an open study with 1 mg of betamethasone given orally twice a day for 21 days. Seven healthy female volunteers, age range 26-55 years, body mass index 19 to 40, mean 27 kg/m2. Total free living energy expenditure was measured by the doubly labelled water method (D2 18O), resting metabolic rate by ventilated hood indirect calorimetry and fat free mass from the dilution volume of oxygen-18 labelled water. Body composition and components of energy expenditure were assessed before and during the final 14 days of betamethasone administration. Weight increased by a mean of 1.2 kg (P < 0.05) because of a significant rise in fat mass (1.5 kg) with no change in fat free mass. Resting metabolic rate remained unaltered on betamethasone but total energy expenditure increased in all subjects with a significant mean rise of 26% from 11.7 to 14.7 MJ/24 h (P < 0.05). The energy component of physical activity with thermogenesis increased on average 52% (from 5.8 to 8.9 MJ/24 h; P < 0.05). The rise in energy expenditure was still apparent after correction for the increase in body weight. Fasting respiratory quotient (RQ) increased from 0.81 to 0.86 with no change in fasting blood glucose. Betamethasone did not result in an energy sparing effect on the two components of energy expenditure studied. Body weight increased on betamethasone entirely due to an increase in fat mass. This occurred despite a rise in total energy expenditure which involved specifically that component accounted for by physical activity plus thermogenesis. The most likely explanation is that betamethasone increased dietary energy intake significantly in excess of expenditure. We estimate that an average extra energy intake of 2.8 MJ/day would have had to be consumed for this rise in fat mass to occur even before taking into account the energy intake cost of the rise in expenditure.Keywords
This publication has 18 references indexed in Scilit:
- Differential Effects of Prednisone and Growth Hormone on Fuel Metabolism and Insulin Antagonism in HumansDiabetes, 1991
- Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humansDiabetes, 1991
- Energy balance in rats given chronic hormone treatmentBritish Journal of Nutrition, 1989
- The doubly-labelled-water (2H218O) method: principles and practiceProceedings of the Nutrition Society, 1988
- Physiological hypercortisolemia increases proteolysis, glutamine, and alanine productionAmerican Journal of Physiology-Endocrinology and Metabolism, 1988
- Automated measurement of the concentration and13C enrichment of carbon dioxide in breath and blood samples using the finnigan MAT breath gas analysis systemJournal of Mass Spectrometry, 1988
- Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range.Journal of Clinical Investigation, 1984
- Prednisolone as an appetite stimulant in patients with cancer.BMJ, 1984
- METABOLIC EFFECTS OF CORTISONEJournal of Endocrinology, 1965
- New methods for calculating metabolic rate with special reference to protein metabolismThe Journal of Physiology, 1949